Workflow
诚惠融
icon
Search documents
东方农商银行“精准滴灌”港城新医药产业
Xin Hua Ri Bao· 2025-09-24 23:50
Group 1 - The financial support of 10 million yuan from Dongfang Rural Commercial Bank is crucial for Jiangsu Beimei Pharmaceutical Co., Ltd., which is establishing a children's medicine production base in Lianyungang [1] - The first phase of the project has a total investment of 133 million yuan and aims to build multiple high-end children's medicine production lines along with intelligent inspection and storage systems [1] - The project commenced construction in October last year and is expected to start trial production in October this year, with an anticipated annual sales revenue of 360 million yuan once fully operational [1] Group 2 - Dongfang Rural Commercial Bank has prioritized the new pharmaceutical industry in Lianyungang as a key area for credit support, utilizing a "loan-investment linkage" model to enhance financial backing for high-quality industrial development [2] - The bank has launched the "Chenghui Rong" special credit product to assist new pharmaceutical enterprises, which typically face long R&D cycles and high investment costs, by providing loans based on state-owned enterprise investment ratios [2] - As of this year, the bank has successfully implemented the "loan-investment linkage" business for four new pharmaceutical enterprises, amounting to 27 million yuan [2] Group 3 - Dongfang Rural Commercial Bank continues to optimize financial supply and innovate service models and product systems, focusing on key livelihood sectors such as aquaculture and agricultural machinery [3] - The bank has issued loans totaling 240 million yuan for freshwater aquaculture, 120 million yuan for marine aquaculture, 277 million yuan for fishing vessel operations, and 2.338 million yuan for agricultural machinery [3] - By the end of June this year, the loan balance for technology-based enterprises reached 1.526 billion yuan, demonstrating the bank's commitment to supporting small and micro enterprises [3] Group 4 - The bank is accelerating its digital transformation to enhance the quality and efficiency of the real economy, exploring "whole-chain credit" cooperation models and promoting the "E Chain Loan" platform [4] - As of the end of June, the bank has issued supply chain loans totaling 907 million yuan, effectively addressing the last mile of service in the industrial chain [4] - The bank's total deposit balance reached 33.229 billion yuan, an increase of 2.753 billion yuan since the beginning of the year, while the total loan balance was 28.329 billion yuan, reflecting a growth of 1.504 billion yuan [4]
东方农商银行再增“投贷联动”赋能新医药产业
Jiang Nan Shi Bao· 2025-09-18 06:26
Core Insights - Dongfang Rural Commercial Bank is aligning with the Lianyungang municipal government's goal of building the "Chinese Medicine Port" by focusing on the new pharmaceutical industry as a key area for credit support [1] - The bank has innovated a "loan-investment linkage" model to increase credit funding, providing financial assistance for high-quality industrial development [1] Summary by Categories Financial Support Initiatives - The bank has introduced the "Chenghui Rong" special credit product to address the common challenges faced by early-stage and growth-stage pharmaceutical companies, such as high R&D investment and low fixed asset ratios [1] - On September 11, the bank's development zone branch issued a loan of 5 million yuan to Jiangsu Mingyi Intelligent Manufacturing Technology Co., Ltd., and on September 12, the Yanhua branch provided a loan of 10 million yuan to Jiangsu Beimei Pharmaceutical Co., Ltd., totaling 15 million yuan [1] Impact on Pharmaceutical Companies - As of September 15, the bank has successfully implemented the "loan-investment linkage" business for four new pharmaceutical enterprises, amounting to 27 million yuan, effectively alleviating financial pressure and accelerating the conversion of technological achievements into industrial applications [1] Future Plans - Dongfang Rural Commercial Bank plans to continue focusing on the new pharmaceutical industry cluster in the city, promoting deep integration of "loan-investment linkage" with industrial chain finance, and providing credit support to upstream and downstream enterprises related to "chain master enterprises" [1]